Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

ClinicalTrials.gov ID: NCT06462586

Public ClinicalTrials.gov record NCT06462586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).

Study identification

NCT ID
NCT06462586
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intra-Cellular Therapies, Inc.
Industry
Enrollment
354 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2024 (Actual)
Primary completion
Feb 24, 2026 (Actual)
Completion
Mar 5, 2026 (Actual)
Last update posted
Jul 24, 2026

2024 – 2026

United States locations

U.S. sites
23
U.S. states
8
U.S. cities
21
Facility City State ZIP Site status
Clinical Site Rogers Arkansas 72758 —
Clinical Site Bellflower California 90706 —
Clinical Site Culver City California 90230 —
Clinical Site Garden Grove California 92845 —
Clinical Site Lemon Grove California 91945 —
Clinical Site Montclair California 91763 —
Clinical Site Hallandale Florida 33009 —
Clinical Site Hialeah Florida 33016 —
Clinical Site Miami Florida 33184 —
Clinical Site Miami Gardens Florida 33056 —
Clinical Site Miami Lakes Florida 33016 —
Clinical Site Miami Springs Florida 33166 —
Clinical Site Orlando Florida 32807 —
Clinical Site Atlanta Georgia 30324 —
Clinical Site Atlanta Georgia 30338 —
Clinical Site Decatur Georgia 30030 —
Clinical Site Savannah Georgia 31405 —
Clinical Site Shreveport Louisiana 71101 —
Clinical Site Marlton New Jersey 08053 —
Clinical Site North Canton Ohio 44720 —
Clinical Site Austin Texas 78701 —
Clinical Site Austin Texas 78754 —
Clinical Site DeSoto Texas 75115 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06462586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06462586 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →